185 related articles for article (PubMed ID: 111943)
1. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
Ebert R; Frerichs H; Creutzfeldt W
Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
Creutzfeldt W; Talaulicar M; Ebert R; Willms B
Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
[TBL] [Abstract][Full Text] [Related]
3. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
4. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
5. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
Ebert R; Creutzfeldt W
Acta Diabetol Lat; 1989; 26(1):1-15. PubMed ID: 2665406
[TBL] [Abstract][Full Text] [Related]
6. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
[TBL] [Abstract][Full Text] [Related]
7. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.
Ebert R; Creutzfeldt W
Diabetologia; 1980 Sep; 19(3):198-204. PubMed ID: 6997121
[TBL] [Abstract][Full Text] [Related]
8. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
[TBL] [Abstract][Full Text] [Related]
9. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
10. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.
Mazzaferri EL; Starich GH; Lardinois CK; Bowen GD
J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608
[TBL] [Abstract][Full Text] [Related]
11. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
Ross SA; Brown JC; Dupré J
Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
[TBL] [Abstract][Full Text] [Related]
12. Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.
Mazzaferri EL; Starich GH; St Jeor ST
J Clin Endocrinol Metab; 1984 Apr; 58(4):640-5. PubMed ID: 6365944
[TBL] [Abstract][Full Text] [Related]
13. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
Ross SA; Dupre J
Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
[TBL] [Abstract][Full Text] [Related]
14. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.
Sarson DL; Kopelman PG; Besterman HS; Pilkington TR; Bloom SR
Diabetologia; 1983 Nov; 25(5):386-91. PubMed ID: 6360777
[TBL] [Abstract][Full Text] [Related]
15. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L
J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
Heptulla RA; Tamborlane WV; Cavaghan M; Bronson M; Limb C; Ma YZ; Sherwin RS; Caprio S
Pediatr Res; 2000 May; 47(5):628-33. PubMed ID: 10813588
[TBL] [Abstract][Full Text] [Related]
17. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies with gastric inhibitory polypeptide.
Brown JC; Otte S
World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
[TBL] [Abstract][Full Text] [Related]
19. Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog.
Pederson RA; Schubert HE; Brown JC
Diabetes; 1975 Dec; 24(12):1050-6. PubMed ID: 1193309
[TBL] [Abstract][Full Text] [Related]
20. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]